InCarda Therapeutics
Signal active
Organization
Contact Information
Overview
InCarda Therapeutics is a clinical-stage drug delivery company pioneering a novel approach of treating acute cardiovascular diseases/conditions by the inhalation route. Lead product is InRhythm, an inhaled formulation of an antiarrhythmic drug to treat acute paroxysmal atrial fibrillation events within minutes at home, at work, or anywhere. Completed Phase 1 and currently advancing lead product through Phase 2.
InCarda Therapeutics was founded in Newark, California.
About
Industries
Biotechnology, Health Care, Therapeutics, Health Diagnostics
Founded
2009
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
InCarda Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics, Health Diagnostics sector. The company focuses on Biotechnology and has secured $8.7B in funding across 112 round(s). With a team of 11-50 employees, InCarda Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Debt Financing - InCarda Therapeutics, raised $310.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
7
Investors
0
Lead Investors
0
Total Funding Amount
$77.9M
Details
4
InCarda Therapeutics has raised a total of $77.9M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Early Stage Venture | 42.0M | ||
| 2013 | Seed | 567.0K | ||
| 2020 | Late Stage Venture | 30.0M | ||
| 2015 | Early Stage Venture | 5.0M |
Investors
InCarda Therapeutics is funded by 16 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Sofinnova Investments | - | FUNDING ROUND - Sofinnova Investments | undefined |
| InCarda Therapeutics | - | FUNDING ROUND - InCarda Therapeutics | undefined |
| InCarda Therapeutics | - | FUNDING ROUND - InCarda Therapeutics | 5.0M |
| Morningside Private Investors | - | FUNDING ROUND - Morningside Private Investors | 5.0M |
Recent Activity
There is no recent news or activity for this profile.